News

February 17, 2020February 17, 2020

Case Report Suggests Lack of Vitamin C as PAH Cause

News, PAH News

Vitamin C deficiency can cause pulmonary arterial hypertension (PAH), a new case report suggests, highlighting the need to test vitamin C levels in people with PAH. The report, “Vitamin ... Read more

February 14, 2020February 14, 2020

Buildup of Oxidized LDLs in Lungs, Plasma Promote PH Progression, Study Shows

News

The buildup in the lungs and plasma of oxidized low-density lipoproteins, or LDLs — one of the major vehicles for the transport of cholesterol and other types of fatty ... Read more

February 12, 2020February 12, 2020

Aria CV’s PH System Designated as Breakthrough Device by FDA

News, PH News

Aria CV‘s medical device for treating pulmonary hypertension (PH) has been given a Breakthrough Device designation by the United States Food and Drug Administration (FDA). The Aria CV PH ... Read more

February 11, 2020February 11, 2020

FDA Efforts to Bring Patients into Treatment Decisions Focus of NORD Webinar

News

The U.S. Food and Drug Administration (FDA), a vast government bureaucracy, employs about 17,500 people and had a budget of $5.7 billion in 2019. Yet even with its enormous ... Read more

February 10, 2020February 10, 2020

Switching to Inhaled Treprostinil Combo Safe, Effective in Stable PAH Patients, Study Suggests

News, PAH News

Switching from injectable treprostinil or epoprostenol to a combination therapy including inhaled treprostinil appears to be safe, well tolerated, and effective for a select group of patients with clinically stable ... Read more

February 7, 2020February 7, 2020

PhaseBio Reports Positive Effects of PB1046 Therapy in PAH Patient in Case Study

News, PAH News

The biopharmaceutical PhaseBio announced positive results from a case study involving a patient with pulmonary arterial hypertension (PAH) who received treatment with PB1046, a new therapy using the company’s ... Read more

February 6, 2020February 6, 2020

With Post-Brexit Move to Amsterdam Complete, EMA Renews Rare Disease Focus

News

The gleaming new Dutch headquarters of the European Medicines Agency (EMA), fronting Domenico Scarlattilaan in Amsterdam’s suburban Zuidas business district, finally opened for business last month — just over ... Read more

February 5, 2020February 5, 2020

‘Team PHenomenal Hope’ Accepting Applications for 2020 Research Award

News, PH News

Seeking to further advance research into treatments for pulmonary hypertension (PH), the nonprofit Team PHenomenal Hope is now accepting submissions for its research award program. Called the PHenomenal Impact ... Read more

February 3, 2020February 6, 2020

FDA Asked to Approve LIQ861, Treprostinil Dry Powder Inhaler for PAH, Liquidia Announces

News, PAH News

Liquidia Technologies is requesting U.S. Food and Drug Administration (FDA) approval of LIQ861, an inhaled dry powder formulation of the vasodilator treprostinil, to treat pulmonary arterial hypertension (PAH). The request came in ... Read more

January 31, 2020January 31, 2020

Sotatercept Eases Heart Strain, Improves Exercise Capacity in PAH, Trial Shows

News, PAH News

Treatment with sotatercept (ACE-011) eased heart strain and improved exercise capacity in individuals with pulmonary arterial hypertension (PAH) participating in the Phase 2 PULSAR trial, according to Acceleron Pharma, the ... Read more

Pin It on Pinterest